Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/30/2007US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
08/30/2007US20070203327 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substanaces
08/30/2007US20070203249 Method for treating cancer
08/30/2007US20070203248 Cardioprotective agents
08/30/2007US20070203247 Epinephrine dosing regimens
08/30/2007US20070203246 Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular Indications
08/30/2007US20070203245 amino(4-methoxy-7,7-dimethyl(7,12,12a,6a-tetrahydrochromano[4,3-b]quinolin-9-yl))methane-1-thione; increasing cellular ATP binding cassette transporter ABCA1 production ; reduces cholesterol deposition in coronary arteries; coronary artery diseases, dyslipidiemias and metabolic syndrome
08/30/2007US20070203244 Inhibitors of membrane type-1 matrix metalloproteinase for the treatment of insulin-dependent diabetes mellitus
08/30/2007US20070203243 Resolution of alpha-(phenoxy) phenylacetic acid derivatives
08/30/2007US20070203242 Method for treating gastric reflux
08/30/2007US20070203241 Antiviral treatments
08/30/2007US20070203240 Personal care compositions and methods for regulating mammalian hair growth
08/30/2007US20070203239 Compounds For The Treatment Of An Acute Injury To The Central Nervous System
08/30/2007US20070203238 Method for preventing or reducing elevated triglyceride levels
08/30/2007US20070203237 Method for preventing or treating obesity
08/30/2007US20070203236 Novel antagonists of the human fatty acid synthase thioesterase
08/30/2007US20070203235 Method for preventing or treating anemia
08/30/2007US20070203234 Cell repair and regeneration by suramin and related polysulfonated napthylureas
08/30/2007US20070203233 NOVEL 2-(alpha-N-PENTANONYL)BENZOATES, THEIR PREPARATION AND USE
08/30/2007US20070203232 treating psychiatric disorder, Parkinson's disease, Alzheimer's disease, dementia, nervous system disorder; ethyl-hydroxymethyl-carbamic acid 3-R-(prop-2-ynylamino)-indan-5-yl ester
08/30/2007US20070203231 Synergistic effect; anxiety disorders, depression
08/30/2007US20070203230 Novel Tricyclic Spiroderivatives as Modulators of Chemokine Receptor Activity
08/30/2007US20070203229 Novel Tricyclic Spiroderivatives as Modulators of Chemokine Receptor Activity
08/30/2007US20070203228 Method for treating chronic obstructive pulmonary disease
08/30/2007US20070203227 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
08/30/2007US20070203226 Calcium receptor antagonists; (R)-4-[(2-Indan-2-yl-1,1-dimethyl-ethylamino)-methyl]-6-oxo-2,5-dioxa-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene-14-carbonitrile; bone disorders; hypoparathyroidism, osteosarcoma, osteoarthritis, rheumatoid arthritis, Paget's disease, humoral , osteoporosis
08/30/2007US20070203225 Method of increasing endogenous adiponectin production and leptin production
08/30/2007US20070203223 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
08/30/2007US20070203222 Substituted gamma lactams as therapeutic agents
08/30/2007US20070203221 Processes for preparing darifenacin hydrobromide
08/30/2007US20070203220 Inhibitors Of PAI-1 For Treatment Of Muscular Conditions
08/30/2007US20070203219 Crystalline 7-methoxycarbonyl-9-(methoxycarbonylmethyl)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-9-azabicyclo[3.3.1]nonane
08/30/2007US20070203218 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide
08/30/2007US20070203217 Substituted stilbenes and their reactions
08/30/2007US20070203216 Method of treating inflammatory diseases
08/30/2007US20070203215 Methods & Compositions For Enhancing Pharmaceutical Treatments
08/30/2007US20070203214 6-Hydroxy-2,2-dimethyl-chroman-4-one; anticancer agents; bioavailability
08/30/2007US20070203213 Administerin mixture of peroxisome proliferator activated receptor and angiotensin receptor antagonist; antidiabetic agents
08/30/2007US20070203212 Method of treating osteoarthritis
08/30/2007US20070203211 Drug for preventing or treating angiogenic eye diseases
08/30/2007US20070203210 Thiazolyl-benzimidazoles
08/30/2007US20070203209 Useful indole compounds
08/30/2007US20070203208 comprises a mixture of insecticides and fungicides; synergistic
08/30/2007US20070203207 Heteroaromatic glucokinase activators
08/30/2007US20070203206 2-Pyrrolidone Derivatives And Use Thereof As Factor Xa Inhibitors
08/30/2007US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol
08/30/2007US20070203203 Composition and Method for Treating Fibrotic Diseases
08/30/2007US20070203202 Methods of reducing adverse events associated with pirfenidone therapy
08/30/2007US20070203201 Substituted anthranilamides for controlling invertebrate pests
08/30/2007US20070203200 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical
08/30/2007US20070203199 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
08/30/2007US20070203198 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes
08/30/2007US20070203197 Phosphodiesterase 4 inhibitors
08/30/2007US20070203196 Methods of preparing indazole compounds
08/30/2007US20070203195 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
08/30/2007US20070203194 Calcium channel modulators comprising 3-thio-4H-1,2,4-triazoles or S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
08/30/2007US20070203193 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/30/2007US20070203192 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety
08/30/2007US20070203190 Hydroxylamines and derivatives for the inhibition of complement activation
08/30/2007US20070203189 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases
08/30/2007US20070203188 Low molecular weight Myc-Max inhibitors
08/30/2007US20070203187 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
08/30/2007US20070203186 N-(trans-4-tert-butylcyclohexyl)-1-{4-[(1h-tetrazol-5-ylamino)carbonyl]benzyl }-3-(3,4,5-trifluoropbenyl)-1h-pyrazole-5-carboxamide; type 2 diabetes, hyperglycemia, diabetes or insulin resistance, Syndrome X, atherosclerosis
08/30/2007US20070203185 Therapeutical Composition Containing Dentritic Cells And Use Thereof
08/30/2007US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them
08/30/2007US20070203183 Diaryl piperidines as CB1 modulators
08/30/2007US20070203182 Alpha-Aminoamide Derivatives Useful In The Treatment Of Restless Legs Syndrome And Addictive Disorders
08/30/2007US20070203180 e.g. 4-[(7-Hydroxy-2-ethyl-3-phenyl-4-quinolinyl)oxyphenyl]-2-propenoic acid; bone diseases, aging, osteoporosis, osteoarthritis, atherosclerosis, menopausal disorders,liver and cardiovascular disorder, breast cancer
08/30/2007US20070203179 Azadecalin Glucocorticoid Receptor Modulators
08/30/2007US20070203178 Crystalline solvates of apixaban
08/30/2007US20070203177 Forms of dolasetron mesylate and processes for their preparation
08/30/2007US20070203176 Crystalline forms of dolasetron base and processes for preparation thereof
08/30/2007US20070203175 Productioin of dolasetron
08/30/2007US20070203174 Method of treating glaucoma
08/30/2007US20070203173 Stable formulations, and methods of their preparation and use
08/30/2007US20070203172 Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same
08/30/2007US20070203171 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same
08/30/2007US20070203170 immunomodulatory agent useful in treatment of restenosis and immune and autoimmune diseases
08/30/2007US20070203169 Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same
08/30/2007US20070203168 Isomers of rapamycin and 42-Epi-rapamycin, methods of making and using the same
08/30/2007US20070203167 2-(Hetero)-aryl substituted tetrahydrochinoline
08/30/2007US20070203166 Administering non-gas containing nanoparticles comprising a mixture of select lipids capable of being internalized within a targeted tissue or cell sufficient to achieve a desired effect and anticancer agent
08/30/2007US20070203165 Compounds and methods for lowering the abuse potential and extending the duration of action of a drug
08/30/2007US20070203164 Methods and compositions for bactericide, bacteriostatic and anti-inflammation
08/30/2007US20070203163 Novel Treatment Of Irritable Bowel Syndrome 1
08/30/2007US20070203162 Prevent transplant rejection; autoimmune diseases
08/30/2007US20070203161 Compositions and methods for inhibition of the jak pathway
08/30/2007US20070203160 p38 MAP kinase inhibitors and methods for using the same
08/30/2007US20070203159 Purine compounds
08/30/2007US20070203157 inhibitors of potassium channel function; to treat arrhythmia; 7-(3,4-Dichlorophenyl)-6-(4-fluorophenylsulfonyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-a]pyrimidine
08/30/2007US20070203156 Oxazole ketones as modulators of fatty acid amide hydrolase
08/30/2007US20070203155 Compounds And Compositions As Ppar Modulators
08/30/2007US20070203154 Therapeutic Compounds
08/30/2007US20070203153 Compositions and methods for treating thrombocytopenia
08/30/2007US20070203152 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203151 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203150 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203149 Ccr5 antagonists useful for treating hiv
08/30/2007US20070203147 2-Aminothiazole Compounds Useful As Aspartyl Protease Inhibitors
08/30/2007US20070203146 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
1 ... 3603 3604 3605 3606 3607 3608 3609 3610 3611 3612 3613 3614 3615 3616 3617 3618 3619 3620 3621 3622 3623 ... 7860